Aller au contenu principal
Profil bibliographique

Weiping Wen

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

22Publications signalées
12Citations signalées
8Affiliations récentes

Les institutions déclarées

Les domaines associés

Head and Neck Cancer StudiesSinusitis and nasal conditionsEsophageal Cancer Research and TreatmentUltrasound Imaging and ElastographyAI in cancer detection

Les publications récentes

Accès ouvert 2026 other OpenAlex

Quantitative dynamic full-field optical coherence tomography for high-resolution intraoperative imaging of head and neck squamous cell carcinoma

Zixuan Huang, Mengyun Zhou, Zhongzhou Luo, K Chen et autres

We present a dynamic full-field optical coherence tomography (D-FFOCT) system providing both structural and dynamic contrast for label-free imaging of head and neck squamous cell carcinoma (HNSCC). The system simultaneously acquires structural and dynamic contrast, enabling visualization of tissue morphology and intracellular …

0 citations Figshare
Accès ouvert 2026 other OpenAlex

Quantitative dynamic full-field optical coherence tomography for high-resolution intraoperative imaging of head and neck squamous cell carcinoma

Zixuan Huang, Mengyun Zhou, Zhongzhou Luo, K Chen et autres

We present a dynamic full-field optical coherence tomography (D-FFOCT) system providing both structural and dynamic contrast for label-free imaging of head and neck squamous cell carcinoma (HNSCC). The system simultaneously acquires structural and dynamic contrast, enabling visualization of tissue morphology and intracellular …

0 citations Figshare
2026 conference-abstract OpenAlex

The PROFOUND study: A large-scale prospective multicenter case-control trial of a multi-cancer early detection (MCED) test in China.

K Chen, Xiang‐Yu Zhao, Guo-Yue Lv, Danbo Wang et autres

10541 Background: Early cancer detection reduces morbidity and mortality, but current recommended screening in China misses many lethal cancers. Emerging liquid biopsy-based MCED tests have the potential to increase the number of screen-detected cancers when added to recommended screening. In this study, …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 conference-abstract OpenAlex

RETRACTED: Neoadjuvant adebrelimab plus chemotherapy in untreated locally advanced head and neck squamous cell carcinoma: Efficacy and biomarker insights from a single-arm phase 2 trial.

Ruihua Fang, Wen Lei, Bixue Huang, Le Chen et autres

6106 Background: Improving outcomes for locally advanced head and neck squamous cell carcinoma (LA-HNSCC) requires novel strategies. This phase 2 trial evaluated the efficacy and safety of neoadjuvant adebrelimab (a PD-L1 inhibitor) combined with chemotherapy in untreated, resectable LA-HNSCC. Methods: In this …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology
2026 article OpenAlex

Management of Parapharyngeal Benign Tumors via Combined Transcervical–Submandibular and Transoral Endoscopic Approach

Zhangwei Hu, Renqiang Ma, Jie Deng, Wei Sun et autres

BACKGROUND: To compare outcomes of the combined transcervical-submandibular and transoral endoscopic approach versus the open transcervical parotid approach and transoral endoscopic surgery alone, and to clarify the indications and advantages of the combined technique. METHODS: This retrospective observational study was conducted at …

cn (code pays fourni par la source)

0 citations Head & Neck
Accès ouvert 2026 article OpenAlex

Neoplasm Adverse Events Associated With Anti‐Type 2 Biologics: An FAERS Database Pharmacovigilance Analysis Study

Wen Lyu, Rui Xu, Le Chen, Wen Lei et autres

BACKGROUND: Biologics targeting Type 2 immune responses, such as omalizumab (anti-IgE), dupilumab (anti-interleukin-4 receptor alpha, anti-IL-4Rα), benralizumab (anti-IL-5R), reslizumab, and mepolizumab (anti-IL-5), are increasingly used clinically. Emerging evidence suggests potential associations between biologics and neoplastic events. METHODS: We analyzed the FDA Adverse …

cn (code pays fourni par la source)

2 citations Cancer Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.